心房颤动患者首次行射频消融术后复发的危险因素及列线图模型的构建

Risk factors and a nomogram for atrial fibrillation recurrence after first-time radiofrequency ablation

  • 摘要: 目的:筛选心房颤动患者首次行射频消融术后复发的危险因素,构建列线图模型并验证其有效性。方法:收集广西医科大学第一附属医院2020年6月至2023年6月首次行射频消融术的230例心房颤动患者的术前临床资料,根据术后随访结局将患者分为复发组和未复发组。采用LASSO回归分析初步筛选预测因子。将患者随机分为训练集和验证集,训练集采用多因素logistic回归分析,最终确定建立列线图的关键变量并构建列线图模型。模型的区分度、校准度及实用性通过受试者工作特征(ROC)曲线、校准曲线及决策曲线进行评价。结果:未复发组与复发组患者单核细胞与高密度脂蛋白胆固醇比值(MHR)0.46(0.37~0.61) vs. 0.63(0.49~0.88),P<0.001、N末端脑钠肽前体(NT-proBNP)270.50(83.91~786.32) vs. 916.55(488.15~1 828.25),P<0.001及左心房直径(LAD)38.00(33.00~44.00) vs. 46.00(40.75~49.00),P<0.001差异均有统计学意义。多因素logistic回归结果显示,MHR(OR=22.530,95%CI:3.88~130.87,P<0.001)、NT-proBNP(OR=1.001,95%CI:1.00~1.01,P=0.003)和LAD(OR=1.080,95%CI:1.01~1.15,P=0.023)是首次行射频消融术后心房颤动复发的独立危险因素。ROC曲线、校准曲线和决策曲线分析表明,基于MHR、NT-proBNP和LAD构建的列线图预测模型在复发风险评估中具有良好的区分度、校准度及临床实用性。结论:MHR、NT-proBNP和LAD是术后房颤复发的独立危险因素,基于此构建的列线图模型在预测复发风险方面具有较高的准确性、可靠性及临床应用价值,可为临床识别心房颤动术后复发提供预测工具。

     

    Abstract: Objective: To identify risk factors for recurrence after the first-time radiofrequency ablation(RFA) procedure in patients with atrial fibrillation, and to construct and validate a nomogram prediction model. Methods: Preoperative clinical data were collected from 230 patients who underwent their first-time RFA for atrial fibrillation at the First Affiliated Hospital of Guangxi Medical University between June 2020 and June 2023. Patients were categorized into a recurrence group and a non-recurrence group depending on their postoperative follow-up outcomes. The least absolute shrinkage and selection operator(LASSO) method was used for preliminary variable screening to establish the nomogram. Patients were randomly allocated to training and validation cohorts. Multivariate logistic regression analysis was performed on the training set to ultimately determine the key variables and construct the nomogram model. Finally, the model's discrimination, calibration, and clinical usefulness were validated using the receiver operating characteristic(ROC) curves, calibration plots, and decision curve analysis. Results: Statistically significant differences were observed between the non-recurrence and recurrence groups in the monocyte-to-high-density lipoprotein cholesterol ratio(MHR) 0.46(0.37-0.61) vs. 0.63(0.49-0.88), P<0.001, N-terminal pro-B-type natriuretic peptide(NT-proBNP) 270.50(83.91-786.32) vs. 916.55(488.15-1,828.25), P<0.001, and left atrial diameter(LAD) 38.00(33.00-44.00) vs. 46.00(40.75-49.00), P<0.001. Multivariate logistic regression analysis identified MHR(OR=22.530, 95% CI: 3.88-130.87, P<0.001), NT-proBNP(OR=1.00, 95% CI: 1.00-1.01, P=0.003), and LAD(OR=1.080, 95% CI: 1.01-1.15, P=0.023) as significant independent factors for atrial fibrillation recurrence after the first-time RFA procedure. ROC curves, calibration curves, and decision curve analysis demonstrated that the nomogram prediction model based on MHR, NT-proBNP, and LAD exhibited good discriminative ability, calibration, and clinical utility in assessing recurrence risk. Conclusion: MHR, NT-proBNP, and LAD are independent risk factors for postoperative atrial fibrillation recurrence. The nomogram model constructed based on these factors demonstrates high accuracy, reliability, and clinical application value in predicting recurrence risk, providing a predictive tool for identifying patients at high risk of recurrence after atrial fibrillation ablation.

     

/

返回文章
返回